Key result
TNF-α treatment of valvular interstitial cell profibrotic activated myofibroblasts leads to increased calcification, potentially mediated by the MAPK/ERK signaling cascade.
Why the study?
Pro-inflammatory cytokines regulate valvular interstitial cell phenotypic changes causing valve calcification, but the specific effects of TNF-alpha on distinct phenotypes remained poorly understood.
TNF-α promotes calcification in profibrotic activated valvular myofibroblasts via the MAPK/ERK pathway, identifying a potential pharmaceutical target for aortic valve disease.
No takes yet. Share an insight, caveat, or question.
TNF-α effects on VIC phenotypes are hypothesis-generating; clinical relevance for valve fibrosis needs in vivo confirmation.
Rodriguez et al. (2021) studied Aortic valve disease. TNF-α was evaluated on Calcification and fibrotic markers (e.g., αSMA, COL1A1, RUNX2, BMP2, and calcium deposits). TNF-α treatment of valvular interstitial cell profibrotic activated myofibroblasts leads to increased calcification, potentially mediated by the MAPK/ERK signaling cascade.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: